Type to search

Tridek-one Closes a €16 Million Financing Round to Develop First-in-class Immune Checkpoint Agonists | Pharmtech Focus
Thabor Therapeutics Appoints Jérémie Mariau as Ceo | Pharmtech Focus
AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II | Pharmtech Focus